Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes

Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes

Sponsors

Lead Sponsor: Hackensack Meridian Health

Collaborator: Verizon Foundation

Source Hackensack Meridian Health
Brief Summary

This is a prospective, randomized trial to evaluate the effectiveness of using educational modules accessed through a bedside tablet in patients newly diagnosed with Type 1 Diabetes as an adjunct to *standard Children's Hospital- Molly Center diabetes education in comparison to *standard Children's Hospital- Molly Center diabetes education. (standard diabetes education consists of paper based reading material and nursing education).

Detailed Description

Type I diabetes is one of the most common diseases of childhood and its incidence has been increasing worldwide. By age 18, 1 in 300 children will be affected by Type 1 Diabetes1. Not only are children diagnosed with diabetes met with significant morbidity due to their disease, but they are also expected to be active participants in daily often complicated treatment regimens. As children with Type 1 diabetes grow older and eventually spend time away from their parents or caregivers, they are forced to manage their own care. Over the last several years, health systems in the United States have become more patient-centered and have focused on autonomy and patient preference. With the advent of technology that makes self-directed education possible, this patient-centered approach needs to be applied to children diagnosed with Type I diabetes. When clinicians are at the center of educating patients with diabetes, they often communicate more directly with parents, who then use the information they receive to manage their child's care. This model, however, does not account for the fact that children with diabetes will one day need to manage their own care and that patients who are active participants and who understand their disease process will be more likely to cooperate with treatment regimens and lifestyle interventions. It is often difficult for any patient, child or adult, to process educational information provided verbally in a physician's office, especially immediately after they have been diagnosed with a life-long disease. Educational tools therefore need to focus on incorporating methods that best serve the patients being educated. Since individuals learn in different ways and at different paces, interactive educational tools can help patients and their families learn in a way that can be individualized and private and can also be fun and creative. As our patients are growing up surrounded by technology, the use of this technology for education might provide a sense of normalcy to children and teenagers already overwhelmed by processes that are often difficult for them to identify with or understand. We hope that patients and families who are given the opportunity to learn independently will become better equipped to manage self-care and will develop a sense of involvement in their treatment. Interactive tools will also help patients and families become more actively engaged in understanding their disease process and can help them to become more active participants in their care.

Overall Status Recruiting
Start Date 2017-04-17
Completion Date 2022-06-01
Primary Completion Date 2022-04-01
Phase N/A
Study Type Interventional
Primary Outcome
Measure Time Frame
Effectiveness of tablet education in newly diagnosed type 1 diabetes Test will be completed on day 3 (+/- 2 days)
Secondary Outcome
Measure Time Frame
Improved subject compliance with glucose monitoring Assessements will occur at 3 months
Enrollment 50
Condition
Intervention

Intervention Type: Other

Intervention Name: Molly Center Diabetes Care Guide (Paper-based)

Description: Diabetes education with Registered Nurse in addition to Paper based education modules

Intervention Type: Other

Intervention Name: Tablet based interactive diabetes education modules

Description: Molly Center Standard Diabetes Education plus access to interactive diabetes education modules through bedside tablet.

Arm Group Label: Group 2

Eligibility

Criteria:

Inclusion Criteria: - New diagnosed Type 1 Diabetes admitted to the Joseph M. Sanzari Children's Hospital - Patient/Caretaker/Family willing to complete questionnaires Exclusion Criteria: - Patients with previous history of Diabetes - Patients with no plans to follow up at The Joseph M. Sanzari Children's Hospital - Molly's Center for Children with Diabetes and Endocrine Disorders after hospital discharge - Non English speaking patients/family/caretaker

Gender:

All

Minimum Age:

N/A

Maximum Age:

21 Years

Healthy Volunteers:

No

Overall Official
Last Name Role Affiliation
Steven Ghanny, MD Principal Investigator Joseph M.Sanzari Children's Hospital at Hackensack University Medical Center
Overall Contact

Last Name: Susan Mathus, BSN

Phone: 551-996-8178

Email: [email protected]

Location
Facility: Status: Contact: Joseph M. Sanzari Children's Hospital Susan Mathus, BSN 551-996-8178 [email protected]
Location Countries

United States

Verification Date

2020-08-01

Responsible Party

Type: Sponsor

Has Expanded Access No
Condition Browse
Number Of Arms 2
Arm Group

Label: Group 1

Type: Other

Description: Participants randomized to Group 1 will receive Standard Diabetic Education with Registered Nurse and Molly Center Diabetes Care Guide (paper-based)

Label: Group 2

Type: Experimental

Description: Participants randomized to Group 2 will receive Molly Center Standard Diabetes Education plus access to Tablet based interactive diabetes education modules

Patient Data No
Study Design Info

Allocation: Randomized

Intervention Model: Parallel Assignment

Intervention Model Description: Participants will be randomized to one of 2 arms: Group 1 - standard Diabetic education-consisting of one on one education with a Registered Nurse in addition to the Molly Center Diabetes Care Guide (paper based) Group 2 - standard Diabetic education plus Bedside tablet with interactive Diabetic modules

Primary Purpose: Supportive Care

Masking: None (Open Label)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Research News